|
summary: This study clarifies the mechanism of action in myofibroblast differentiation of the new immunomodulator FTY720, recently introduced in MS therapy.
authors: Keller CD, Rivera Gil P, Tolle M, van der Giet M, Chun J, Radeke HH, Schafer-Korting M, Kleuser B.
source: Am J Pathol. 2007 Jan;170(1):281-92.
weblink: click here
category: Cell Biology
related research news: click here
glossary:
Fibroblast
Immunoglobulin
Immunosuppressio
Physical
Sign
|
